• Cdc42–β-Catenin Signaling in Kidney Fibrosis

  2026-09-03

  The 2024 Advanced Science study identifies daphnepedunin A, a natural diterpenoid from Wikstroemia chamaedaphne, as an anti-fibrotic compound that directly targets Cdc42. Its proposed mechanism links reduced Cdc42 activity to PKCζ/GSK-3β regulation, β-catenin degradation, and reduced fibroblast activation in cellular and unilateral ureteral obstruction models.

• Stiripentol LDH Inhibitor Research Workflows

  2026-09-03

  Stiripentol is a research-grade LDH inhibitor that connects astrocyte-neuron lactate shuttle modulation with metabolic and epigenetic assay design. This workflow guide shows how to evaluate lactate flux, histone lactylation, immune-cell function, and seizure-relevant phenotypes while controlling solubility and vehicle-related artifacts.

• (Z)-4-Hydroxytamoxifen ER Workflow Guide

  2026-09-02

  Build more interpretable estrogen receptor experiments with (Z)-4-Hydroxytamoxifen, from solvent handling and dose design to orthogonal pathway validation. This guide also shows how delivery, retention, and genetic-control principles from a cartilage nanoparticle study can sharpen breast cancer assay logic without overstating cross-domain evidence.

• DOT1L Reprograms Immunity in Multiple Myeloma

  2026-09-02

  The 2025 Cancer Letters study shows that DOT1L inhibition activates STING-linked innate immune signaling and disrupts oncogenic transcriptional programs in multiple myeloma. Its combination with lenalidomide strengthens interferon-regulated gene expression and suppresses IRF4–MYC signaling, providing a mechanistic rationale for epigenetic–immunomodulatory drug combinations.

• n-Dodecyl-β-D-maltoside (DDM) Guide

  2026-09-01

  n-Dodecyl-β-D-maltoside (DDM) is a non-ionic maltoside detergent for membrane protein solubilization and stabilization. Its practical value depends on protein identity, lipid composition, buffer conditions, and downstream assay compatibility.

• Glycogen Colorimetric Assay Kit II Workflow

  2026-09-01

  The Glycogen Colorimetric Assay Kit II provides a practical route to compare tissue glycogen across exercise time points, disease models, and metabolic interventions. Its enzymatic hydrolysis and colorimetric readout are suited to plate-based glycogen measurement in samples where reducing substances can complicate oxidase-based methods.

• QX77 Molecular Chaperone Activator Workflows

  2026-08-31

  QX77 provides a practical route for testing LAMP2A- and Rab11-linked chaperone-mediated autophagy in cell and stem-cell models. This guide combines handling advice, quantitative pilot designs, differentiation assays, and a cautious framework for relating CMA findings to mitochondrial autophagy research.

• A23187, Free Acid: Calcium Ionophore Guide

  2026-08-30

  A23187, free acid is a calcium ionophore used to increase intracellular Ca2+ and investigate phosphoinositide signaling, reactive oxygen species, metabolism, and apoptosis. Product specifications and model-specific evidence support its use as a research perturbagen, but they do not establish a universal dose or a disease-treatment effect.

• Sequencing Therapy in Waldenström Macroglobulinemia

  2026-08-29

  The 2021 review by Sarosiek, Treon, and Castillo proposes a precision-oriented framework for sequencing Waldenström macroglobulinemia therapy according to clinical presentation, patient priorities, prior treatment, and MYD88 or CXCR4 status. Its central practical implication is that covalent BTK inhibitors, chemoimmunotherapy, proteasome inhibitor regimens, transplantation, and clinical trials should be selected as context-dependent options rather than applied in a universal sequence.

• Human iPSC Models for Schizophrenia and Bipolar Disorder

  2026-08-29

  The reference study established three human induced pluripotent stem cell lines from related female donors representing first-episode schizophrenia, bipolar disorder, and an unaffected cousin. Their normal karyotypes, pluripotency-marker expression, and tri-lineage differentiation capacity make them a useful starting resource for modeling psychiatric neurodevelopment, while their small and family-limited design defines important boundaries for interpretation.

• Olive Biophenols and Alzheimer’s Pathology: Key Findings

  2026-08-28

  The reference study integrates cell-based amyloid toxicity assays with an APPswe/PS1dE9 mouse model to examine whether olive biophenols can limit amyloid-β aggregation and pathology. Oleuropein-containing olive leaf extract reduced plaque deposition in the cortex and hippocampus, while oleuropein, verbascoside, and rutin showed prominent anti-amyloidogenic activity in vitro.

• Epalrestat Neuroprotection in Parkinson’s Disease

  2026-08-28

  Jia et al. identify a neuroprotective role for Epalrestat in cellular and mouse Parkinson’s disease models, linking the compound to direct KEAP1 engagement, Nrf2 activation, reduced oxidative stress, and improved mitochondrial function. The study provides a mechanistic rationale for repurposing an established aldose reductase inhibitor, while its toxin-based and pretreatment-focused design leaves clinical translation unresolved.

• M344: Designing Causal HDAC Assays

  2026-08-27

  M344 is a cell-permeable histone deacetylase inhibitor for dissecting chromatin-dependent changes in proliferation, differentiation, radiation response, and viral latency. This guide uses endpoint logic from comparative clinical research to build more rigorous M344 assays.

• n-Dodecyl-β-D-maltoside (DDM) for Membrane Proteins

  2026-08-27

  n-Dodecyl-β-D-maltoside, commonly called DDM, is a non-ionic maltoside detergent for membrane protein solubilization, stabilization, purification, and reconstitution. Its micelle-forming behavior supports functional studies, but concentration, solution composition, adsorption, and storage conditions require empirical control.

• IWP-2 as a Wnt Production Inhibitor for Assay Design

  2026-08-26

  IWP-2 is a potent Wnt production inhibitor that enables researchers to interrogate ligand-dependent Wnt biology rather than only downstream β-catenin responses. This article connects Porcupine inhibition with assay logic inspired by SHANK3 epigenetic research, highlighting controls, readouts, and cross-domain limitations.

455 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page